Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Life Science Institute Prepares for World-First Clinical Trials Using Muse Cells

Filed Under: Pharma Tagged With: , , , ,

The Life Science Institute Inc., a group company under Mitsubishi Chemical Holdings Corp. (TYO:4188), plans to begin clinical trials in…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
Tokyo Tech Devises a New Generation of BPA for Use in Chemical Surgery
Tokyo Tech Devises a New Generation of BPA for Use in…
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
Tokyo Institute of Technology, Kanto Chemical Develop Growth Medium for iPS Cell-Derived Small Intestine Models
Tokyo Institute of Technology, Kanto Chemical Develop Growth…